Cargando…

The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size

The receptor tyrosine kinase (RTK) EphA2 is expressed in epithelial and endothelial cells and controls the assembly of cell–cell junctions. EphA2 has also been implicated in many diseases, including cancer. Unlike most RTKs, which signal predominantly as dimers, EphA2 readily forms high-order oligom...

Descripción completa

Detalles Bibliográficos
Autores principales: Zapata-Mercado, Elmer, Biener, Gabriel, McKenzie, Daniel M., Wimley, William C., Pasquale, Elena B., Raicu, Valerica, Hristova, Kalina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512837/
https://www.ncbi.nlm.nih.gov/pubmed/35970390
http://dx.doi.org/10.1016/j.jbc.2022.102370
_version_ 1784797921035681792
author Zapata-Mercado, Elmer
Biener, Gabriel
McKenzie, Daniel M.
Wimley, William C.
Pasquale, Elena B.
Raicu, Valerica
Hristova, Kalina
author_facet Zapata-Mercado, Elmer
Biener, Gabriel
McKenzie, Daniel M.
Wimley, William C.
Pasquale, Elena B.
Raicu, Valerica
Hristova, Kalina
author_sort Zapata-Mercado, Elmer
collection PubMed
description The receptor tyrosine kinase (RTK) EphA2 is expressed in epithelial and endothelial cells and controls the assembly of cell–cell junctions. EphA2 has also been implicated in many diseases, including cancer. Unlike most RTKs, which signal predominantly as dimers, EphA2 readily forms high-order oligomers upon ligand binding. Here, we investigated if a correlation exists between EphA2 signaling properties and the size of the EphA2 oligomers induced by multiple ligands, including the widely used ephrinA1-Fc ligand, the soluble monomeric m-ephrinA1, and novel engineered peptide ligands. We used fluorescence intensity fluctuation (FIF) spectrometry to characterize the EphA2 oligomer populations induced by the different ligands. Interestingly, we found that different monomeric and dimeric ligands induce EphA2 oligomers with widely different size distributions. Our comparison of FIF brightness distribution parameters and EphA2 signaling parameters reveals that the efficacy of EphA2 phosphorylation on tyrosine 588, an autophosphorylation response contributing to EphA2 activation, correlates with EphA2 mean oligomer size. However, we found that other characteristics, such as the efficacy of AKT inhibition and ligand bias coefficients, appear to be independent of EphA2 oligomer size. Taken together, this work highlights the utility of FIF in RTK signaling research and demonstrates a quantitative correlation between the architecture of EphA2 signaling complexes and signaling features.
format Online
Article
Text
id pubmed-9512837
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Biochemistry and Molecular Biology
record_format MEDLINE/PubMed
spelling pubmed-95128372022-09-30 The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size Zapata-Mercado, Elmer Biener, Gabriel McKenzie, Daniel M. Wimley, William C. Pasquale, Elena B. Raicu, Valerica Hristova, Kalina J Biol Chem Methods and Resources The receptor tyrosine kinase (RTK) EphA2 is expressed in epithelial and endothelial cells and controls the assembly of cell–cell junctions. EphA2 has also been implicated in many diseases, including cancer. Unlike most RTKs, which signal predominantly as dimers, EphA2 readily forms high-order oligomers upon ligand binding. Here, we investigated if a correlation exists between EphA2 signaling properties and the size of the EphA2 oligomers induced by multiple ligands, including the widely used ephrinA1-Fc ligand, the soluble monomeric m-ephrinA1, and novel engineered peptide ligands. We used fluorescence intensity fluctuation (FIF) spectrometry to characterize the EphA2 oligomer populations induced by the different ligands. Interestingly, we found that different monomeric and dimeric ligands induce EphA2 oligomers with widely different size distributions. Our comparison of FIF brightness distribution parameters and EphA2 signaling parameters reveals that the efficacy of EphA2 phosphorylation on tyrosine 588, an autophosphorylation response contributing to EphA2 activation, correlates with EphA2 mean oligomer size. However, we found that other characteristics, such as the efficacy of AKT inhibition and ligand bias coefficients, appear to be independent of EphA2 oligomer size. Taken together, this work highlights the utility of FIF in RTK signaling research and demonstrates a quantitative correlation between the architecture of EphA2 signaling complexes and signaling features. American Society for Biochemistry and Molecular Biology 2022-08-13 /pmc/articles/PMC9512837/ /pubmed/35970390 http://dx.doi.org/10.1016/j.jbc.2022.102370 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Methods and Resources
Zapata-Mercado, Elmer
Biener, Gabriel
McKenzie, Daniel M.
Wimley, William C.
Pasquale, Elena B.
Raicu, Valerica
Hristova, Kalina
The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size
title The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size
title_full The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size
title_fullStr The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size
title_full_unstemmed The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size
title_short The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size
title_sort efficacy of receptor tyrosine kinase epha2 autophosphorylation increases with epha2 oligomer size
topic Methods and Resources
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512837/
https://www.ncbi.nlm.nih.gov/pubmed/35970390
http://dx.doi.org/10.1016/j.jbc.2022.102370
work_keys_str_mv AT zapatamercadoelmer theefficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize
AT bienergabriel theefficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize
AT mckenziedanielm theefficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize
AT wimleywilliamc theefficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize
AT pasqualeelenab theefficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize
AT raicuvalerica theefficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize
AT hristovakalina theefficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize
AT zapatamercadoelmer efficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize
AT bienergabriel efficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize
AT mckenziedanielm efficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize
AT wimleywilliamc efficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize
AT pasqualeelenab efficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize
AT raicuvalerica efficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize
AT hristovakalina efficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize